Not only is Dr. Jay Haynie the Executive Clinical Director of Retina and Macula Specialists, but he's also been a clinical investigator for Rainier Research, which has provided ocular examinations for patients undergoing experimental drug therapy for diabetes, cholesterol, and diabetic neuropathy. In this series, Saving Sight, Preventing Vision Loss in Diabetic Retinopathy and Diabetic Macular Edema, hear his expertise on treating vision-threatening eye diseases in patients with diabetes.
Dr. Jay M. Haynie is the Executive Clinical Director of Retina and Macula Specialists with offices in Washington State. He graduated from Pacific University College of Optometry and completed a residency at American Lake Veterans Hospital in Tacoma, WA. He has been a clinical investigator for Rainier Research, providing ocular examinations for patients undergoing experimental drug therapy for diabetes, cholesterol and diabetic neuropathy. He serves as Adjunct Assistant Professor at Pacific University College of Optometry, a Fellow of the American Academy of Optometry and a member of the Optometric Retina Society. He is a published author and has become a nationally recognized speaker on new technology and treatment of retinal and macular disease.
Peter K. Kaiser, MDPeer